Add 2 More Reports For 20% off

Report Overview

The global companion diagnostics market was valued at USD 7.45 Billion in 2023, driven by increasing incidence of cancer and chronic diseases across the globe. The market is expected to grow at a CAGR of 12.00% during the forecast period of 2024-2032, with the values likely to reach USD 20.66 Billion by 2032.

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

  • The demand for companion diagnostics is on the rise, to combat the burden of cancer and other chronic diseases. Approximately 1 in 5 people develop cancer in their lifetime.
  • One of the major market trends includes rising collaborations between key companies to provide improved diagnostics procedures for patients.
  • The North America region is likely to experience notable growth in the forecast period. Increased healthcare infrastructure spending and the strong regulatory support is boosting its market value.

Compound Annual Growth Rate

Value in USD Billion

12%

2024-2032


Companion Diagnostics Market Outlook

*this image is indicative*

Companion Diagnostics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Companion Diagnostics Market Overview

Companion diagnostics are in vitro medical devices used to determine if a particular treatment is suitable for a specific patient. This diagnostic method is fundamental in personalized treatment. It aims to improve the efficacy of a treatment regimen and minimize side effects and is mostly used in oncology where targeted therapies can be used to battle cancer. According to the American  Cancer Society, the number of cancer cases based on the projected population growth are predicted to increase to 35 million by 2050. The market growth is further driven by adoption of personalized treatment, and technological advancements like next-generation sequencing among others.

Global Companion Diagnostics Market Growth Drivers

Increasing Prevalence of Cancer Cases to Affect the Market Landscape Significantly

With rising incidence of cancer, the market has been expressing an influx of new and innovative products to provide enhanced patient outcomes. In October  2023, QIAGEN and Myriad Genetics partnered to develop advanced companion diagnostics for cancer. The collaboration focused on developing advance diagnostic tests so that cancer treatments can be patient specific. The initial projects under this partnership were expected to utilize next-generation sequencing and QIAGEN’s digital PCR platform, QIAcuity, to develop assays for various cancer types.

Growth in Strategic Partnerships and Mergers to Meet Rising Companion Diagnostics Market Demand

In February 2024, Roche  entered into a collaboration agreement with PathAI to expand its digital pathology capabilities specifically for companion diagnostics. This partnership with PathAI aimed on developing artificial intelligence (AI)-enabled digital pathology algorithms with Roche Tissue Diagnostics (RTD). The use of the algorithm would be aimed at advancing the filed of pathology and boosting precision in diagnostics leading to clinical care and drug development.

In January 2024, Agilent  Technologies Inc., collaborated with Incyte to develop companion diagnostics in oncology and hematology. The collaboration is intended to utilize Agilent’s capabilities in developing and marketing in-vitro diagnostic assays alongside Incyte’s growing portfolio of therapeutic products.

Global Companion Diagnostics Market Trends

The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:

Key Trends Impact
Expanding Indications Started from oncology, companion diagnostics is utilized in other therapeutic areas like infectious diseases, inflammatory conditions, and cardiovascular diseases. The widespread use is acknowledged by the fact that it can enhance outcomes across several fields and provide tailored treatment based on specific patient profiles.
Focus On Precision Medicine Precision medicine includes tailoring medical treatments to the requirements of individual patients, generally based on biomolecular, genetic, or clinical data. This optimizes clinical outcomes and companion diagnostics are vital medical devices offering information about patient’s condition or expected response to a treatment.
Rising healthcare Expenditures Increasing healthcare investments aimed at improving the healthcare infrastructure is one the major market trends. Healthcare providers and payers are willing to adapt advanced diagnostic technologies that can improve patient outcomes and reduce overall healthcare costs.
Advancements in Technologies Robust advancement in technologies is crucial for improving the precision and duration of tests to identify molecular and genetic marker. Technology like next-generation sequencing (NGS), allows deeper analysis of DNA with high sensitivity in detecting genomic variations. Polymerase chain reaction (PCR) amplifies tiny strands of DNA which can be analyzed effectively and hence provide precision in examination. This improves diagnostic accuracy leading to better alternatives for patients.

Global Companion Diagnostics Market Segmentation

Market Breakup by Product

  • Assays
  • Kits & Reagents
  • Software & Services

Market Breakup by Technology

  • Next-Generation Sequencing
  • In Situ Hybridization
  • Immunohistochemistry
  • Others

Market Breakup by Indication

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Others

Market Breakup by End User

  • Pharmaceutical & Biopharmaceutical Companies
  • Reference Laboratories
  • Contract Research Organizations
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Companion Diagnostics Market By Segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Companion Diagnostics Market Share

Market Segmentation Based on Product is Anticipated to Grow Significantly

Based on product, the market segmentation includes assays, kits and reagents, along with software and services. Assays are used in the identification of therapeutic targets like biomarkers or genetic profiles in patients to provide effective treatment plan, particularly in oncology. They act a core component, driving precision in treatments and hence contributes to the companion diagnostics market value. For the continuity of diagnostics, kits and reagents facilitates these assays by supplying the essential tools and consumables.

Fastest growth is projected in the software and services segment, attributed to its function in interpretation and integration of data into healthcare systems. With rise in personalized treatments, demand for software solution to manage complex diagnostic data is on the rise, leading to the increase in companion diagnostics market value.

Lung Cancer is Expected to Hold a Significant the Market Share

The segments by indication include lung cancer, breast cancer, colorectal cancer, and others. According to the World  Cancer Research Fund International, worldwide lung cancer is the second most common type of cancer. Due to the high incidence and the crucial need for targeted therapies, lung cancer is projected to lead the market, propelling the demand for companion diagnostics to identify targeted treatments relied on genetic markers.

With advancements and better insights of genetic mutations in the BRCA1 and BRCA2 markers, breast cancer diagnostics is also reflecting significant growth. Exploration and development of biomarkers and therapies for melanoma are on the rise. The diversity in cancer and the genomic precision are driving the market value.

Companion Diagnostics Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Companion Diagnostics Market Analysis by Region

Regionally, the market report offers an insight into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America leads the market followed by Europe, robust healthcare infrastructure with high spending and strong regulatory support with government initiatives promoting targeted therapies along with research conducted in oncology diagnostics, propels the regional market share.

Asia Pacific is anticipated to experience considerable growth, which can be attributed to the increase in healthcare expenditure, awareness regarding personalized treatment options, and the swift development of healthcare infrastructure in emerging economies like India, Japan, South Korea and China.

Leading Players in the Global Companion Diagnostics Market

The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

  • F. Hoffmann-La Roche Ltd
  • Agilent Technologies, Inc.
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • Almac Group
  • Resonance Health Ltd
  • Illumina, Inc.
  • BIOMÉRIEUX
  • Myriad Genetics, Inc.
  • Siemens Healthcare Private Limited
  • Abbott
  • Exact Sciences Corporation
  • Guardant Health
  • ASURAGEN, INC.

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in the Global Companion Diagnostics Market Report

  • What was the global companion diagnostics market value in 2023?
  • What is the global companion diagnostics market forecast outlook for 2024-2032?
  • What are the regional markets covered in the EMR report?
  • What is market segmentation based on product?
  • What is the market breakup based on indication?
  • Who are the major end users in the market?
  • What type of technologies are present in the market?
  • What are the major factors aiding the global companion diagnostics market demand? 
  • How has the companion diagnostics market performed so far and how is it anticipated to perform in the coming years?
  • What are the market's major drivers, opportunities, and restraints? 
  • Which regional market is expected to lead the market share in the forecast period? 
  • Which country is expected to witness expedited growth during the forecast period? 
  • How does the prevalence and incidence of cancer affect the market landscape?
  • What are the major global companion diagnostics market trends?
  • What product will dominate the market share? 
  • Which technology type will experience the highest demand in the market segment?
  • Who are the key players involved in the companion diagnostics market?
  • What is patent landscape of the market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers and acquisitions among the key market players shaping the market dynamics?

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product
  • Technology
  • Indication
  • End User
  • Region
Breakup by Product
  • Assays
  • Kits & Reagents
  • Software & Services
Breakup by Technology
  • Next-Generation Sequencing
  • In Situ Hybridization
  • Immunohistochemistry
  • Others
Breakup by Indication
  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Others
Breakup by End User
  • Pharmaceutical & Biopharmaceutical Companies
  • Reference Laboratories
  • Contract Research Organizations
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered F. Hoffmann-La Roche Ltd
Agilent Technologies, Inc.
QIAGEN
Thermo Fisher Scientific Inc.
Almac Group
Resonance Health Ltd
Illumina, Inc.
BIOMÉRIEUX
Myriad Genetics, Inc.
Siemens Healthcare Private Limited
Abbott
Exact Sciences Corporation
Guardant Health
ASURAGEN, INC.
 

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63 287899028, +63 967 048 3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124